PEER-REVIEWED PUBLICATIONS

Tchantchou, F., Y. Xu, et al. (2007) EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. FASEB J. 21. PDF

Brown, M K, Evans, J L, and Luo, Y. (2006) Beneficial effects of natural antioxidants EGCG and alpha-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans. Pharmacol Biochem Behav. PDF

Wu, Y, Wu, Z, Butko, P, Christen, Y, Lambert, M P, Klein, W L, Link, C D, and Luo, Y. (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci. 26, 13102-13. PDF

Luo, Y. (2006) Alzheimer’s disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract. Life Sci 78(18): 2066-72. PDF

Gutierrez-Zepeda, A., Santell, R, Wu, Z, Brown, M. Wu, Y., Khan, I., Link, C.D., Zhao, B., Luo, Y. (2005) Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic C. elegans. BMC Neuroscience 6:54. PDF

Guan, J., Luo, Y., Denker, B. (2005) Pcp2 (Purkinje cell protein-2) stimulates differentiation in PC12 cells by Gbg-mediated activation of ras and p38 MAP kinase. Biochem J. 392:389:397. PDF

Wu, Y.J & Luo, Y (2005) Transgenic C.elegans as a model in Alzheimer’s research. Current Alzheimer Research 2:37-45. PDF

Smith, J.V. & Luo, Y. (2004) Studies on molecular mechanisms of Ginkgo biloba. Appl. Microbiol. Biotechnol. 64:465-472. PDF

Luo, Y. (2004) Long-lived worms and aging. Redox Report 9:65-69.PDF

Gutierrez-Zepeda, A & Luo, Y. (2004) Testing the amyloid toxicity hypothesis of Alzheimer’s disease in transgenic Caenorhabditis elegans model. Frontier Biosciences 9: 3333-3338. PDF

Strayer, A., Wu, Z-X, Christen, Y., Link, C. & Luo, Y. (2003) Expression of the small heat-shock protein Hsp-16-2 in Caenorhabditis elegans is suppressed by Ginkgo biloba extract EGb 761. FASEB J. 17:376.PDF

Smith, J. V. & Luo, Y. (2003) Elevation of oxidative free radicals in Alzheimer’s disease models can be attenuated by Ginkgo biloba extract EGb 761. J. Alzheimer’s disease 5, 287-300.PDF

Luo, Y. (2003) Contemporary Neuroscience Meets Traditional Medicine – Towards Understanding Ginkgo Biloba Neuroprotection. Current Topics in Nutraceutical Research 1:49-57.PDF

Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A. Curry, K.J., Buford, J., Khan, I., Netzer, W.J., Xu, H, Butko, P. (2002) Inhibition of Amyloid-b Aggregation and Caspase 3 Activation by the Ginkgo biloba Extract EGb761. Proc. Natl. Acad. Sci. 99:12197-12202.PDF

Wu, Z., Smith, J. V., Paramasivam, V., Butko, P., Khan, I., J.R. Cypser, J.R. & Luo, Y. (2002) Ginkgo biloba Extract EGb761 Increases Stress Resistance and Extends Life Span of Caenorhabditis elegans. Cellular & Molecular Biology 48:725-731.

Smith, J.V., Burdick, A.J., Golik, P., Khan, I., Wallace, D. & Luo, Y. (2002) Anti-apoptotic Properties of Ginkgo biloba Extract EGb761 in Differentiated PC12 Cells. Cellular & Molelucar Biology 48:699-707.

Ward, C. P., Redd, K. J., Luo, Y. & McCoy, J. (2002) Ginkgo biloba extract: Cognitive enhancer or antistress buffer. Pharm. Biochem. & Behavior  72(4):913-922. PDF

Redd, K. J., Oberdick, J., McCoy, J., Denker, B. M, Luo, Y. (2002) Association and Co-localization of G Protein alpha Subunits and Purkinje Cell Protein 2 (Pcp2) in Mammalian Cerebellum. J. Neuroscience Res. 70(5):631-637. PDF

Luo, Y. (2001) Ginkgo biloba neuroprotection: therapeutic implications in Alzheimer’s disease. J. Alzheimer’s Disease  3:401-407. PDF

Williams, B., Luo, Y., Wards, C., Redd, K. J. and J. McCoy, J. (2001) Environmental enrichment: effects on spatial memory and hippocampal CREB immunoreactivity. J. Physiology & Behavior  73:649-658.PDF